www.email.biopharminternational.com Open in urlscan Pro
2606:2c40::c73c:67e4 Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
https://d2vln-04.na1.hubspotlinks.com/Ctc/I9+113/d2Vln-04/VVvRc-3DztMfN4ldG6LJ34J6W8BHpjy59_9TbN3X6VJn5kBVqW95jVnq6lZ3mMN3NKbjSpzvVrW6...
Effective URL:
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-...
Submission: On February 27 via api (February 27th 2024, 3:58:20 am UTC) from SA — Scanned from DE

Summary HTTP 9 Redirects Links 6 Behaviour Indicators

Summary

This website contacted 3 IPs in 1 countries across 3 domains to perform 9 HTTP transactions. The main IP is 2606:2c40::c73c:67e4, located in United States and belongs to CLOUDFLARESPECTRUM Cloudflare, Inc., US. The main domain is www.email.biopharminternational.com.
TLS certificate: Issued by GTS CA 1P5 on January 1st 2024. Valid for: 3 months.

This is the only time www.email.biopharminternational.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 2	2606:4700::68... 2606:4700::6812:bc9	13335 (CLOUDFLAR...) (CLOUDFLARENET)
6	2606:2c40::c7... 2606:2c40::c73c:67e4	209242 (CLOUDFLAR...) (CLOUDFLARESPECTRUM Cloudflare)
2	2606:4700::68... 2606:4700::6811:dab1	13335 (CLOUDFLAR...) (CLOUDFLARENET)
9	3

2 2606:4700::6812:bc9 (United States) 1 redirects

ASN13335 (CLOUDFLARENET, US)

d2vln-04.na1.hubspotlinks.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2606:2c40::c73c:67e4 (United States)

ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US)

www.email.biopharminternational.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2606:4700::6811:dab1 (United States)

ASN13335 (CLOUDFLARENET, US)

hs-24460541.f.hubspotemail.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
6	biopharminternational.com www.email.biopharminternational.com	52 KB
2	hubspotemail.net hs-24460541.f.hubspotemail.net — Cisco Umbrella Rank: 737732	5 KB
2	hubspotlinks.com 1 redirects d2vln-04.na1.hubspotlinks.com — Cisco Umbrella Rank: 282896	4 KB
9	3

	Domain	Requested by
6	www.email.biopharminternational.com	d2vln-04.na1.hubspotlinks.com www.email.biopharminternational.com
2	hs-24460541.f.hubspotemail.net	www.email.biopharminternational.com
2	d2vln-04.na1.hubspotlinks.com	1 redirects
9	3

This site contains links to these domains. Also see Links.

Domain
www.biopharminternational.com
globalmeet.webcasts.com
www.linkedin.com
twitter.com
hs-24460541.s.hubspotemail.net

Subject Issuer	Validity	Valid
hubspotlinks.com Cloudflare Inc ECC CA-3	`2023-04-17` - `2024-04-16`	a year	crt.sh
www.email.biopharminternational.com GTS CA 1P5	`2024-01-01` - `2024-03-31`	3 months	crt.sh
hubspotemail.net Cloudflare Inc ECC CA-3	`2023-04-01` - `2024-03-31`	a year	crt.sh

This page contains 1 frames:

Primary Page: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email
Frame ID: A89A2494BD77DD172DAC335D2CEDA1FD
Requests: 9 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

[Executive Summary] Factors to Consider When Determining the Best Approach for Constructing a New Facility

Page URL History Show full URLs

https://d2vln-04.na1.hubspotlinks.com/Ctc/I9+113/d2Vln-04/VVvRc-3DztMfN4ldG6LJ34J6W8BHpjy59_9TbN3X6VJn5kBVqW95jVnq... Page URL
https://d2vln-04.na1.hubspotlinks.com/events/public/v1/encoded/track/tc/I9+113/d2Vln-04/VVvRc-3DztMfN4ldG6LJ34J6W8... HTTP 307
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for... Page URL

Page Statistics

9
Requests

100 %
HTTPS

100 %
IPv6

3
Domains

3
Subdomains

3
IPs

1
Countries

60 kB
Transfer

96 kB
Size

2
Cookies

6 Outgoing links

These are links going to different origins than the main page.

URL: https://www.biopharminternational.com/view/prefabricated-modular-construction-the-good-the-bad-and-the-not-so-obvious-benefits?utm_source=sfmc&utm_medium=email&utm_campaign=mktg_execsummary&_hsenc=p2ANqtz--ovNzQbI0i0j8K6Z224ffUQNv2L42ft3v7_7d5gQBEHW49dWM04iiks3PlkVKIURQBvDBMxxQ9P9-xG5aBbNZE8KSFOA
Title: Prefabricated Modular Construction: The Good, the Bad, and the Not So Obvious Benefits

Search URL Search Domain Scan URL

URL: https://globalmeet.webcasts.com/starthere.jsp?ei=1628207&tp_key=ab09fc4092&sti=mjhes&utm_source=hs_email&utm_medium=email&utm_content=295403658&_hsenc=p2ANqtz--ovNzQbI0i0j8K6Z224ffUQNv2L42ft3v7_7d5gQBEHW49dWM04iiks3PlkVKIURQBvDBMxxQ9P9-xG5aBbNZE8KSFOA

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/biopharm-international/?utm_source=hs_email&utm_medium=email&utm_content=295403658&_hsenc=p2ANqtz--ovNzQbI0i0j8K6Z224ffUQNv2L42ft3v7_7d5gQBEHW49dWM04iiks3PlkVKIURQBvDBMxxQ9P9-xG5aBbNZE8KSFOA

Search URL Search Domain Scan URL

URL: https://twitter.com/BioPharmIntl?utm_source=hs_email&utm_medium=email&utm_content=295403658&_hsenc=p2ANqtz--ovNzQbI0i0j8K6Z224ffUQNv2L42ft3v7_7d5gQBEHW49dWM04iiks3PlkVKIURQBvDBMxxQ9P9-xG5aBbNZE8KSFOA

Search URL Search Domain Scan URL

URL: https://hs-24460541.s.hubspotemail.net/preferences/en/unsubscribe?data=W2nXS-N30h-SHW1VcDDx41JCH-W3QC6nf34n-fyW4fMBrW2TLJvpW2qDmMr1BFXHZW3jpSvB3_s-60W2WvFwh4hxLxXW4klTgJ3yRTbGW1Vzjxh49Qww1W3bm67q2-pb77W3XYNtw4cKdNpW1V94dD2Krr51W1S1W6p2x-pNpW1Slt7n1SbFxKW3XPl5d1Xfz0nW2HGm3G214DyMW45z8GV3SYgLzW3FfKlx3brljsW3VS1Sv3z7YW6W3QPzPv2HsvJYW3d351h1SfW1dW2D04rb2-br1HW252xbP3NPLMxW3VRJ363gnPCTW45xTgv1ShBdYW4fhzVq4tFjPgW1ZsBXR2KWsnVW1Sz7vb4pzbJBW1-ZdQS3NTygJW2CH6HD3XGkbXW1Q4CjC2CTb6KW3JWFs03f_bk0W3zbRW23T5VYhW49zyDx4rwQF1W49k9KM3yWC2pW1B9xQb3M9MsR0&utm_source=hs_email&utm_medium=email&utm_content=295403658&_hsenc=p2ANqtz--ovNzQbI0i0j8K6Z224ffUQNv2L42ft3v7_7d5gQBEHW49dWM04iiks3PlkVKIURQBvDBMxxQ9P9-xG5aBbNZE8KSFOA
Title: Unsubscribe

Search URL Search Domain Scan URL

URL: https://hs-24460541.s.hubspotemail.net/preferences/en/manage?data=W2nXS-N30h-GcW4mGhpr3bg_pjW4rjHPl3_TBvwW4hGk3-3QKW62W3dsLxj1Bmv-zW1_9knl1ZdR__W38shcM4tft1BW49Lj_Q2xJQSFW2p1Hhc32j_4wW4fqJRv1Vy5_CW34lZc53Z-80BW3VZQf21Sf5PFW2WjyT73zd34QW2-JsnN1ZmYGNW2ztY972TBjSJW1X6WNb2WrL1vW2nFT_d3bqwJJW2xNxKR1_rsy3W1NDRsS2C_fpwW2KpNgw329xbFW41rrC63gcDnPW38zDCx2HqmZZW238Xcz25lKl3W1X5Z__2z-cvNW1BCRk-257YsHW4mm_5R3_V152W4hfMrn3h_N5yW2zxsZ041QVp1W4cKGHX21mZfJW2xyt6V3gwX8mW2Pl27l3f-k-2W3XMj-F1-VBPWW4hGnqx2sTBkkW4ctlvH3dc0S4W3K1DJH3C2NmxW2y1L1w3zdZFc0&utm_source=hs_email&utm_medium=email&utm_content=295403658&_hsenc=p2ANqtz--ovNzQbI0i0j8K6Z224ffUQNv2L42ft3v7_7d5gQBEHW49dWM04iiks3PlkVKIURQBvDBMxxQ9P9-xG5aBbNZE8KSFOA
Title: Manage preferences

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

https://d2vln-04.na1.hubspotlinks.com/Ctc/I9+113/d2Vln-04/VVvRc-3DztMfN4ldG6LJ34J6W8BHpjy59_9TbN3X6VJn5kBVqW95jVnq6lZ3mMN3NKbjSpzvVrW63PHlW13Lx-qW43Lk-F5CgGg_VdskYd53cb4GW1HkNQ47xZgBCW61Dvnq8DFN1dW1QDYvf158KRSW7Pdpm912LRyzW8PT3cy8P-WBzW3zhQ4z77PNr3N5MxJcVP4Tk3W6yf7557vMNgRW98kkd42vF6n8W8fyKjy47FNPNVbsbwW5qkf0RW5pG7TH5-V0BTN25mSN5PZVNNMtLSc9LHyM8N2XPqj3Jhft7N15X7QshX55lW3LwhpP5pWKfjW1NMKWZ5JC3WNN4yj6vyPm4F2W4Xr-tX9bqdWZW98NYKc2HwqVgW21FTYq6LZ2cnW3_VW1S615W-JW1npDBS8JrlnnW1xS4_53PMYRgV81FP42Nl0TDVJc2tD3mS8VqW9h7LNL5WGqMSW8NCcsH8yMQf2MwBfjm_BymqW31p6yr8fh5ChW44bwcF5JK_XmW5gy1RN1PdSqGW3thf4X4W6tRTW27sW3P295cYBW3YG8t77kZrBVW99S9zF3PmY8QVgWGwt7SpFJ2W3YTWkZ3YbKqFVQH7Gs4D31pxW7TbKh326Kmq9W59XjQ15t56Z8f5vH18d04 Page URL
https://d2vln-04.na1.hubspotlinks.com/events/public/v1/encoded/track/tc/I9+113/d2Vln-04/VVvRc-3DztMfN4ldG6LJ34J6W8BHpjy59_9TbN3X6VJn5kBVqW95jVnq6lZ3mMN3NKbjSpzvVrW63PHlW13Lx-qW43Lk-F5CgGg_VdskYd53cb4GW1HkNQ47xZgBCW61Dvnq8DFN1dW1QDYvf158KRSW7Pdpm912LRyzW8PT3cy8P-WBzW3zhQ4z77PNr3N5MxJcVP4Tk3W6yf7557vMNgRW98kkd42vF6n8W8fyKjy47FNPNVbsbwW5qkf0RW5pG7TH5-V0BTN25mSN5PZVNNMtLSc9LHyM8N2XPqj3Jhft7N15X7QshX55lW3LwhpP5pWKfjW1NMKWZ5JC3WNN4yj6vyPm4F2W4Xr-tX9bqdWZW98NYKc2HwqVgW21FTYq6LZ2cnW3_VW1S615W-JW1npDBS8JrlnnW1xS4_53PMYRgV81FP42Nl0TDVJc2tD3mS8VqW9h7LNL5WGqMSW8NCcsH8yMQf2MwBfjm_BymqW31p6yr8fh5ChW44bwcF5JK_XmW5gy1RN1PdSqGW3thf4X4W6tRTW27sW3P295cYBW3YG8t77kZrBVW99S9zF3PmY8QVgWGwt7SpFJ2W3YTWkZ3YbKqFVQH7Gs4D31pxW7TbKh326Kmq9W59XjQ15t56Z8f5vH18d04?_ud=d2b7dff8-2499-4dc1-a3d6-4006e97d80c8&_jss=1&_fl=8&_pl=3&_hc=4&_lg=en-US,en&_plt=Win32&_scr=1600,1200 HTTP 307
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

9 HTTP transactions
0 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2 200 VVvRc-3DztMfN4ldG6LJ34J6W8BHpjy59_9TbN3X6VJn5kBVqW95jVnq6lZ3mMN3NKbjSpzvVrW63PHlW13Lx-qW43Lk-F5CgGg_VdskYd53cb4GW1HkNQ47xZgBCW61Dvnq8DFN1dW1QDYvf158KRSW7Pdpm912LRyzW8PT3cy8P-WBzW3zhQ4z77PNr3N5MxJcV...
d2vln-04.na1.hubspotlinks.com/Ctc/I9+113/d2Vln-04/ 8 KB
3 KB 333ms
316ms Document
text/html 2606:4700::6812:bc9
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://d2vln-04.na1.hubspotlinks.com/Ctc/I9+113/d2Vln-04/VVvRc-3DztMfN4ldG6LJ34J6W8BHpjy59_9TbN3X6VJn5kBVqW95jVnq6lZ3mMN3NKbjSpzvVrW63PHlW13Lx-qW43Lk-F5CgGg_VdskYd53cb4GW1HkNQ47xZgBCW61Dvnq8DFN1dW1QDYvf158KRSW7Pdpm912LRyzW8PT3cy8P-WBzW3zhQ4z77PNr3N5MxJcVP4Tk3W6yf7557vMNgRW98kkd42vF6n8W8fyKjy47FNPNVbsbwW5qkf0RW5pG7TH5-V0BTN25mSN5PZVNNMtLSc9LHyM8N2XPqj3Jhft7N15X7QshX55lW3LwhpP5pWKfjW1NMKWZ5JC3WNN4yj6vyPm4F2W4Xr-tX9bqdWZW98NYKc2HwqVgW21FTYq6LZ2cnW3_VW1S615W-JW1npDBS8JrlnnW1xS4_53PMYRgV81FP42Nl0TDVJc2tD3mS8VqW9h7LNL5WGqMSW8NCcsH8yMQf2MwBfjm_BymqW31p6yr8fh5ChW44bwcF5JK_XmW5gy1RN1PdSqGW3thf4X4W6tRTW27sW3P295cYBW3YG8t77kZrBVW99S9zF3PmY8QVgWGwt7SpFJ2W3YTWkZ3YbKqFVQH7Gs4D31pxW7TbKh326Kmq9W59XjQ15t56Z8f5vH18d04

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:bc9 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

access-control-allow-credentials: false
cf-cache-status: DYNAMIC
cf-ray: 85bd82190d890410-FRA
content-encoding: br
content-type: text/html;charset=utf-8
date: Tue, 27 Feb 2024 03:58:14 GMT
referrer-policy: no-referrer
server: cloudflare
vary: origin
x-content-type-options: nosniff
x-envoy-upstream-service-time: 18
x-evy-trace-listener: listener_https
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-route-service-name: envoyset-translator
x-evy-trace-served-by-pod: iad02/event-tracking-td/envoy-proxy-5c6d56bb5f-mlb8n
x-evy-trace-virtual-host: all
x-hubspot-correlation-id: c49ab941-9933-4a61-ac5e-e690e43333c8
x-request-id: c49ab941-9933-4a61-ac5e-e690e43333c8
x-robots-tag: none

GET
H2

200

Primary Request executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024 Show response
www.email.biopharminternational.com/
Redirect Chain

https://d2vln-04.na1.hubspotlinks.com/events/public/v1/encoded/track/tc/I9+113/d2Vln-04/VVvRc-3DztMfN4ldG6LJ34J6W8BHpjy59_9TbN3X6VJn5kBVqW95jVnq6lZ3mMN3NKbjSpzvVrW63PHlW13Lx-qW43Lk-F5CgGg_VdskYd53c...
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOq...

42 KB
7 KB

469ms
415ms

Document
text/html

2606:2c40::c73c:67e4
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to

Full URL

https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email

Requested by

Host: d2vln-04.na1.hubspotlinks.com
URL: https://d2vln-04.na1.hubspotlinks.com/Ctc/I9+113/d2Vln-04/VVvRc-3DztMfN4ldG6LJ34J6W8BHpjy59_9TbN3X6VJn5kBVqW95jVnq6lZ3mMN3NKbjSpzvVrW63PHlW13Lx-qW43Lk-F5CgGg_VdskYd53cb4GW1HkNQ47xZgBCW61Dvnq8DFN1dW1QDYvf158KRSW7Pdpm912LRyzW8PT3cy8P-WBzW3zhQ4z77PNr3N5MxJcVP4Tk3W6yf7557vMNgRW98kkd42vF6n8W8fyKjy47FNPNVbsbwW5qkf0RW5pG7TH5-V0BTN25mSN5PZVNNMtLSc9LHyM8N2XPqj3Jhft7N15X7QshX55lW3LwhpP5pWKfjW1NMKWZ5JC3WNN4yj6vyPm4F2W4Xr-tX9bqdWZW98NYKc2HwqVgW21FTYq6LZ2cnW3_VW1S615W-JW1npDBS8JrlnnW1xS4_53PMYRgV81FP42Nl0TDVJc2tD3mS8VqW9h7LNL5WGqMSW8NCcsH8yMQf2MwBfjm_BymqW31p6yr8fh5ChW44bwcF5JK_XmW5gy1RN1PdSqGW3thf4X4W6tRTW27sW3P295cYBW3YG8t77kZrBVW99S9zF3PmY8QVgWGwt7SpFJ2W3YTWkZ3YbKqFVQH7Gs4D31pxW7TbKh326Kmq9W59XjQ15t56Z8f5vH18d04

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

77e7e8c1fb5cbf3a7f74b463618dfe3b0f9d42a0209d5e7ec4e79e47db778cae

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff

Request headers

Referer: https://d2vln-04.na1.hubspotlinks.com/Ctc/I9+113/d2Vln-04/VVvRc-3DztMfN4ldG6LJ34J6W8BHpjy59_9TbN3X6VJn5kBVqW95jVnq6lZ3mMN3NKbjSpzvVrW63PHlW13Lx-qW43Lk-F5CgGg_VdskYd53cb4GW1HkNQ47xZgBCW61Dvnq8DFN1dW1QDYvf158KRSW7Pdpm912LRyzW8PT3cy8P-WBzW3zhQ4z77PNr3N5MxJcVP4Tk3W6yf7557vMNgRW98kkd42vF6n8W8fyKjy47FNPNVbsbwW5qkf0RW5pG7TH5-V0BTN25mSN5PZVNNMtLSc9LHyM8N2XPqj3Jhft7N15X7QshX55lW3LwhpP5pWKfjW1NMKWZ5JC3WNN4yj6vyPm4F2W4Xr-tX9bqdWZW98NYKc2HwqVgW21FTYq6LZ2cnW3_VW1S615W-JW1npDBS8JrlnnW1xS4_53PMYRgV81FP42Nl0TDVJc2tD3mS8VqW9h7LNL5WGqMSW8NCcsH8yMQf2MwBfjm_BymqW31p6yr8fh5ChW44bwcF5JK_XmW5gy1RN1PdSqGW3thf4X4W6tRTW27sW3P295cYBW3YG8t77kZrBVW99S9zF3PmY8QVgWGwt7SpFJ2W3YTWkZ3YbKqFVQH7Gs4D31pxW7TbKh326Kmq9W59XjQ15t56Z8f5vH18d04
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

access-control-allow-credentials: false
alt-svc: h3=":443"; ma=86400
cache-control: s-maxage=7200,max-age=5
cache-tag: CT-158031526951,P-24460541,PGS-ALL,SW-4
cf-cache-status: MISS
cf-ray: 85bd821c59d018d9-FRA
content-encoding: br
content-security-policy: upgrade-insecure-requests
content-type: text/html;charset=utf-8
date: Tue, 27 Feb 2024 03:58:14 GMT
edge-cache-tag: CT-158031526951,P-24460541,PGS-ALL,SW-4
last-modified: Tue, 27 Feb 2024 03:58:14 GMT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
referrer-policy: no-referrer-when-downgrade
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=SrLm297aj3TJNkDHqfCaxeUjpzkjUlfYWqbcd2cTPCCTUXnrX1sv%2B7NT4z48Kpd0mo9yHCSiX%2FlviOEJ%2BX5xME83LC3SZQz6HcMIeVMXM7Yl3H6Q6AvHNE3heakSLZl1zzquYuBbJqZJPGzfDpivfJATmiB%2BIPirmxgykjp%2FOoHp"}],"group":"cf-nel","max_age":604800}
server: cloudflare
strict-transport-security: max-age=31536000
vary: origin, Accept-Encoding
x-content-type-options: nosniff
x-envoy-upstream-service-time: 225
x-evy-trace-listener: listener_https
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-route-service-name: envoyset-translator
x-evy-trace-served-by-pod: iad02/cms-40-49-td/envoy-proxy-6d8575499-clpm6
x-evy-trace-virtual-host: all
x-hs-cache-config: BrowserCache-5s-EdgeCache-7200s
x-hs-content-id: 158031526951
x-hs-hub-id: 24460541
x-hubspot-correlation-id: 0891209b-92f0-48f0-8f7b-dd1497a2c93a
x-request-id: 0891209b-92f0-48f0-8f7b-dd1497a2c93a
x-trace: 2B1E57F2C6EDF3E3E34047AE904933409835D93724000000000000000000

Redirect headers

access-control-allow-credentials: false
cf-cache-status: DYNAMIC
cf-ray: 85bd821b1e590410-FRA
date: Tue, 27 Feb 2024 03:58:14 GMT
link: <https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email>; rel="canonical"
location: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email
referrer-policy: no-referrer
server: cloudflare
vary: origin
x-content-type-options: nosniff
x-envoy-upstream-service-time: 39
x-evy-trace-listener: listener_https
x-evy-trace-route-configuration: listener_https/all
x-evy-trace-route-service-name: envoyset-translator
x-evy-trace-served-by-pod: iad02/event-tracking-td/envoy-proxy-5c6d56bb5f-llqnq
x-evy-trace-virtual-host: all
x-hubspot-correlation-id: 0a92134d-32bd-49a2-b424-41872b447372
x-request-id: 0a92134d-32bd-49a2-b424-41872b447372
x-robots-tag: none

GET
H2 200 header.jpg
www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/ 10 KB
10 KB 31ms
30ms Image
image/webp 2606:2c40::c73c:67e4
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/header.jpg?upscale=true&width=1200&upscale=true&name=header.jpg

Requested by

Host: www.email.biopharminternational.com
URL: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

91072f71582cd71a09dd3a0237a17e4eab372b22fbf74bd4db425d63864b41b8

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date: Tue, 27 Feb 2024 03:58:14 GMT
via: 1.1 7a6b4cd1254095c5b4b5ec2c3af1870a.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
cache-tag: F-154185516409,FD-154184359988,P-24460541,FLS-ALL
alt-svc: h3=":443"; ma=86400
content-length: 9832
cf-resized: internal=ok/m q=0 n=842+0 c=1+17 v=2024.1.3 l=9832
last-modified: Wed, 24 Jan 2024 17:49:06 GMT
cf-bgj: imgq:86,h2pri
server: cloudflare
etag: "cf_EHWw30MS9stItlVvzjQd8Mjp_JT3RFRkAkfKe_HDQ:762f1dc63e3952c5bf89506ff93f2253"
vary: Accept, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=TK%2FsDiu34mMzt%2Fj33NPXYKyA6EE91ShbZKFIzmX5iE07iG2iNtv5qEiiLBxGoXGFe1gkbDm0zlPRJ%2F0jz31W%2BAwkgfkISygwYMnmCoM2caTWRxz0lLTBEzX5jgHe2C%2FgJlklUUvUAE67M96qpAQl2pgVn32zSCRdtU0puHYxrhp5"}],"group":"cf-nel","max_age":604800}
content-type: image/webp
access-control-allow-origin: *
cache-control: s-maxage=2592000, max-age=1209600, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 85bd821efb0c18d9-FRA

GET
H2 200 summaryCover.jpg
www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/ 6 KB
7 KB 35ms
34ms Image
image/webp 2606:2c40::c73c:67e4
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/summaryCover.jpg?upscale=true&width=300&upscale=true&name=summaryCover.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

86a90202509aabe17633df642feb14367d9aa52c6574ef3a9896243002481b42

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date: Tue, 27 Feb 2024 03:58:14 GMT
via: 1.1 b08e1d433d62b5ab056680968a8cc7ea.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
cache-tag: F-154186249297,FD-154184359988,P-24460541,FLS-ALL
alt-svc: h3=":443"; ma=86400
content-length: 6634
cf-resized: internal=ok/m q=0 n=850+0 c=0+5 v=2024.1.3 l=6634
last-modified: Wed, 24 Jan 2024 17:54:06 GMT
cf-bgj: imgq:86,h2pri
server: cloudflare
etag: "cfVDyIxsnILEgvLvNrPg5Jmwk9Pv3fHRErO2kJZaYSDQ:a6dec232e42e53673d7a6e5051543bd3"
vary: Accept, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=2PlRBOmfwY%2FAIRkHZM8ZHn7snoC%2BgurSxlPmyIGFmKv4NL7fCKwGCp266C15Va4AuS0I7F6%2Bl6raTZTCQ%2F2hRmKzycdxy8dLstIZH%2BkyHgp2v3MrOWBy%2BoztU8lETS%2FnZS0W8HiaizP%2B%2BLDDjLvdfivCz8JsVFpfz4jsqw5om0%2BQ"}],"group":"cf-nel","max_age":604800}
content-type: image/webp
access-control-allow-origin: *
cache-control: s-maxage=2592000, max-age=1209600, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 85bd821efb0d18d9-FRA

GET
H2 200 regPage.jpg
www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/ 7 KB
8 KB 27ms
26ms Image
image/webp 2606:2c40::c73c:67e4
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/regPage.jpg?upscale=true&width=300&upscale=true&name=regPage.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

c3e892c2989a747ee3dcaf81db88dee956adc2483b2a369efe17a3b76926fe38

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date: Tue, 27 Feb 2024 03:58:14 GMT
via: 1.1 256cd380c9790a2b71d68709829caa18.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
cache-tag: F-154187353443,FD-154184359988,P-24460541,FLS-ALL
alt-svc: h3=":443"; ma=86400
content-length: 7502
cf-resized: internal=ok/m q=0 n=859+0 c=0+20 v=2024.1.3 l=7502
last-modified: Wed, 24 Jan 2024 17:54:04 GMT
cf-bgj: imgq:86,h2pri
server: cloudflare
etag: "cfuZWlGtL5qHujKFhxwc1gfVw-Pv3fHRErO2kJZaYSDQ:0ca75b61a4741c3d9be12f7bb659b144"
vary: Accept, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=3z9NtRXb6uubMP1Io7bh8wkOWfMR%2F%2FwCUX3aiyk%2FCWEKddxy%2BZvegoMVeefMVSZxOsm4lJ%2FrErzh5dwtREt3Ldj0UdqNipuTyAY5d610U%2Bqqz5YQ16ufSaqD4KoWib%2F7JuyHpGsVEk4%2B%2Bn9ox7GZefsjktT4sbaMtTDq4g6KUkYy"}],"group":"cf-nel","max_age":604800}
content-type: image/webp
access-control-allow-origin: *
cache-control: s-maxage=2592000, max-age=1209600, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 85bd821f0b1418d9-FRA

GET
H2 200 biopharm.png
www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/ 7 KB
7 KB 31ms
30ms Image
image/webp 2606:2c40::c73c:67e4
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/biopharm.png?upscale=true&width=450&upscale=true&name=biopharm.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

5e0d94875809da71c3218cc23bbd1d83b5d7ba002feb93bbc26f31425bb02b79

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date: Tue, 27 Feb 2024 03:58:14 GMT
via: 1.1 b08e1d433d62b5ab056680968a8cc7ea.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
cache-tag: F-154184360027,FD-154184359988,P-24460541,FLS-ALL
alt-svc: h3=":443"; ma=86400
content-length: 6784
cf-resized: internal=ok/m q=0 n=887+0 c=5+26 v=2024.1.3 l=6784
last-modified: Wed, 24 Jan 2024 17:49:01 GMT
cf-bgj: imgq:86,h2pri
server: cloudflare
etag: "cfcYaBnjibSyzIb964AeHKe0WP4W08S3YyiQfIvN6zDQ:14b104925e1f868d0fdaee557013c255"
vary: Accept, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=zkmSRoh5f65Nu7lotsuNQwSdmT9h9JwyNR3yuTPPhHIdurU%2FRLFCEn%2BWagFmgLmiXgJDE8pCtx7%2FUxE1L62BwH%2B80%2BLlrVb%2FpjGfHkBGvLgp9mHopgp2czZBu39Ev0hUHZ%2FwtOmPX6z9AniTJC4vLgzSOm6gkMCZNjm4USZJvNEL"}],"group":"cf-nel","max_age":604800}
content-type: image/webp
access-control-allow-origin: *
cache-control: s-maxage=2592000, max-age=1209600, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 85bd821f0b1518d9-FRA

GET
H2 200 gcon.png
www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/ 12 KB
12 KB 32ms
31ms Image
image/webp 2606:2c40::c73c:67e4
CLOUDFLARESPECTRU...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/gcon.png?upscale=true&width=450&upscale=true&name=gcon.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),

Reverse DNS

Software

cloudflare /

Resource Hash

8e1ea1fb3b1c2f4df0142fcd87ce21d7dd0726b38963cceaaf5a5444bd705ecb

Security Headers

Name	Value
Content-Security-Policy	default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date: Tue, 27 Feb 2024 03:58:14 GMT
via: 1.1 3e28473376ca49b2cafcfef86a39cf34.cloudfront.net (CloudFront)
x-content-type-options: nosniff
cf-cache-status: HIT
nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy: default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
cache-tag: F-154185288525,FD-154184359988,P-24460541,FLS-ALL
alt-svc: h3=":443"; ma=86400
content-length: 12002
cf-resized: internal=ok/m q=0 n=862+0 c=2+23 v=2024.1.3 l=12002
last-modified: Wed, 24 Jan 2024 17:48:57 GMT
cf-bgj: imgq:86,h2pri
server: cloudflare
etag: "cf8Cxf4guvnhuedmpwn1SsAMKq4W08S3YyiQfIvN6zDQ:a07fc58be842744ab9aed062988afd64"
vary: Accept, Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=K77ZFjIrwK3Kfs%2B7Ezn3XXR8uxjCTaddU%2Fy7UXvFnFTXkzFcssHywldjaqGo%2FlG03WC1RH%2BpDfokY2M54uU6dPSHobRI%2FjYew%2BGAFi3KmnwlBw%2BhRGLyXfzF%2Bh%2FGqUGuRgRKJbr1hr72bwvWHw02lAxa0SsRBynkNoqXpo%2Fqu%2FIl"}],"group":"cf-nel","max_age":604800}
content-type: image/webp
access-control-allow-origin: *
cache-control: s-maxage=2592000, max-age=1209600, stale-while-revalidate=900
accept-ranges: bytes
cf-ray: 85bd821f0b1618d9-FRA

GET
H2 200 linkedin_circle_color.png
hs-24460541.f.hubspotemail.net/hs/hsstatic/TemplateAssets/static-1.262/img/hs_default_template_images/modules/Follow+Me+-+Email/ 1 KB
1 KB 71ms
37ms Image
image/png 2606:4700::6811:dab1
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://hs-24460541.f.hubspotemail.net/hs/hsstatic/TemplateAssets/static-1.262/img/hs_default_template_images/modules/Follow+Me+-+Email/linkedin_circle_color.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:dab1 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

a4d09d81cd7505339ba3ab4a685d1fea0dc3130155a49e5c9123f2b5fad1d149

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date: Tue, 27 Feb 2024 03:58:14 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
via: 1.1 bc3ecf5f025b0be9b8c39c5dd2dace2e.cloudfront.net (CloudFront)
cf-cache-status: HIT
x-amz-version-id: sVwKg68BgiHAiI1gZ9UYWF67w57kzLrn
age: 3423036
x-amz-cf-pop: FRA60-P6
x-amz-server-side-encryption: AES256
x-cache: Hit from cloudfront
x-amz-replication-status: COMPLETED
content-length: 1116
last-modified: Wed, 20 Dec 2023 15:32:09 GMT
server: cloudflare
etag: "27594239f030ba18f4fde5d48917d57d"
vary: Accept-Encoding
content-type: image/png
cache-control: public, max-age=31536000
accept-ranges: bytes
cf-ray: 85bd821f3a7c371f-FRA
x-amz-cf-id: cP1zetrxvb0WaX3KqEfDNZ_PzJwM-xXn9Z5NLNk5Xqb438-voN1s2Q==
expires: Wed, 26 Feb 2025 03:58:14 GMT

GET
H2 200 twitter_circle_color.png
hs-24460541.f.hubspotemail.net/hs/hsstatic/TemplateAssets/static-1.262/img/hs_default_template_images/modules/Follow+Me+-+Email/ 3 KB
4 KB 69ms
36ms Image
image/png 2606:4700::6811:dab1
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://hs-24460541.f.hubspotemail.net/hs/hsstatic/TemplateAssets/static-1.262/img/hs_default_template_images/modules/Follow+Me+-+Email/twitter_circle_color.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6811:dab1 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

fa65d03e7627af254881f94bd0e4446f246ea36c0a40d8365cd64f1f22670613

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024?ecid=ACsprvv5IvIi6q03Zh5y-SojmD56vwAmtOqTOUZuhmiH32hbOxNR5WaSyMFnbepxYzje-HBgkSxX&utm_medium=email&_hsmi=295403658&_hsenc=p2ANqtz--fKzsWGMOlhDrI48064f-TZUIgKaBa-fIWC6f05TVMPFY9qJmMO7b66U0tczCPWcuzPKuUyubuzRd7dg9pZ4XPDXNpPw&utm_content=295403658&utm_source=hs_email
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date: Tue, 27 Feb 2024 03:58:14 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
via: 1.1 146c0f4d7da9f5b3108ac41c3becbb82.cloudfront.net (CloudFront)
cf-cache-status: HIT
x-amz-version-id: XEZ0EE1eMPmtjcGiB5HyqF1VItz1lzhS
age: 3422745
x-amz-cf-pop: FRA60-P6
x-amz-server-side-encryption: AES256
x-cache: Hit from cloudfront
x-amz-replication-status: COMPLETED
content-length: 3291
last-modified: Wed, 20 Dec 2023 15:32:09 GMT
server: cloudflare
etag: "bc7502d9383cee242e9d89f57e912878"
vary: Accept-Encoding
content-type: image/png
cache-control: public, max-age=31536000
accept-ranges: bytes
cf-ray: 85bd821f3a7a371f-FRA
x-amz-cf-id: A-7s2zhmkXTpk3KRvOxZctMwZP6nRE45hc471L5qG030aAsWJBzVZQ==
expires: Wed, 26 Feb 2025 03:58:14 GMT

Verdicts & Comments Add Verdict or Comment

0 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

2 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

			Domain/Path	Expires	Name / Value
			.www.email.biopharminternational.com/	1970-01-20 18:43:28	Name: __cf_bm Value: VtdDhTtr.tgC4hjg5WiVdDIUE0sI2hFOxKWpkGYf.Ac-1709006294-1.0-ASAnfWGSXBqiuHX1KGcXXjtzMVe9RNjHAFU+KxGgzRcpo6zrmXdbY+i4MEtrvszcRV69SjVr5N2MKxoCN4Q9088=
			.www.email.biopharminternational.com/	1969-12-31 23:59:59	Name: __cfruid Value: 96c8b9324ddc00be164d0317cea07e104318c23b-1709006294

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
X-Content-Type-Options	nosniff

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

d2vln-04.na1.hubspotlinks.com
hs-24460541.f.hubspotemail.net
www.email.biopharminternational.com
2606:2c40::c73c:67e4
2606:4700::6811:dab1
2606:4700::6812:bc9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www.email.biopharminternational.com Open in urlscan Pro 2606:2c40::c73c:67e4 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Page URL History Show full URLs

Page Statistics

9 Requests

100 %HTTPS

100 %IPv6

3 Domains

3 Subdomains

3 IPs

1 Countries

60 kBTransfer

96 kBSize

2 Cookies

6 Outgoing links

Page URL History

Redirected requests

9 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 0 data transactions

Request headers

Response headers

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Verdicts & Comments Add Verdict or Comment

0 JavaScript Global Variables

2 Cookies

Security Headers

Indicators

www.email.biopharminternational.com Open in urlscan Pro
2606:2c40::c73c:67e4 Public Scan

Screenshot
Live screenshot

Full Image

9
Requests

100 %
HTTPS

100 %
IPv6

3
Domains

3
Subdomains

3
IPs

1
Countries

60 kB
Transfer

96 kB
Size

2
Cookies

9 HTTP transactions
0 data transactions